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The dynamics of changes in membrane potential, cytosolic free Ca*+, [Caz+lI and immunoreactive insulin 
release were assessed in RINmSF cells. Membrane depolarization and a rise in [CaZ+lI preceded the stimula- 
tion of insulin release by D-glyceraldehyde. Forskolin, which raised the cellular cyclic AMP levels, stimu- 
lated insulin release without changing membrane potential or [Caz+],. It is concluded that cyclic AMP acts 
on insulin release not by mobilizing Ca 2+ but by another, as yet undefined, mechanism. 
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1. INTRODUCTION 
Both Ca’+ and cyclic AMP have been proposed 
as intracellular mediators of glucose-induced in- 
sulin release (review, [1,2]). Recently, the mediator 
function of Ca2+ has been strengthened by the fin- 
ding that the concentration of cytosolic free Ca’+, 
[Ca’+]i, increases during the stimulation of insulin- 
secreting cells with the triose glyceraldehyde [3] or 
glucose itself [4,5]. In contrast, an increase of 
cellular cyclic AMP levels does not always accom- 
pany glucose-induced insulin release, making 
cyclic AMP a less likely direct mediator than Ca2+ 
[2,6]. Therefore, the main role of cyclic AMP is 
now generally considered to be that of potentiating 
insulin release [2]. 
or D-glyceraldehyde in the insulin-secreting cell 
line RINmSF [ 10,111. Forskolin, a substance which 
activates adenylate cyclase [12], was found to raise 
the cellular cyclic AMP levels without increasing 
[Ca’+li, while glyceraldehyde-induced insulin 
release is preceded by a rise in [Ca2+]i without an 
accompanying change in cyclic AMP levels. 
2. EXPERIMENTAL 
It has been suggested that cyclic AMP may 
potentiate insulin release by mobilizing Ca2+ from 
intracellular stores. This idea was based on 
measurements of 45Ca2+ efflux from pancreatic 
islets preloaded with the isotope, where 
theophylline, 3-isobutyl-1-methylxanthine and 
dibutyryl cyclic AMP were found to increase 
45Ca2+ efflux [7-91. 
Here, we have directly measured changes in 
[Ca2+]i and insulin release in response to forskolin 
RINmSF cells [lo] were cultured, transferred to 
spinner cultures and loaded with quin2 acetox- 
ymethyl ester [13] (100 PM) as in [3]. Loaded and 
control cells were kept at 18-20°C in medium 
RPM11640 supplemented with 25 mM Hepes until 
use. Intracellular quin2 fluorescence was moni- 
tored on cells resuspended in a modified Krebs- 
Ringer-bicarbonate buffer containing 5 mM 
NaHC03, 1.1 mM CaCl2, 25 mM Hepes, 0.1 mM 
EGTA and 2.8 mM glucose. The cells were re- 
suspended in 2 nl of this buffer at a final concen- 
tration of l-2 x lo6 cells/ml. Quin2 fluorescence 
was measured in glass cuvettes thermostatted to 
37°C under continuous stirring. The fluorescence 
was measured with excitation and emission wave- 
lengths of 339 and 492 nm, respectively, in a 
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Perkin-Elmer LS3 spectrofluorometer. The cali- 
bration of the signal was as in [3]. D-Glyceralde- 
hyde was added to the cuvettes from a 1 M aque- 
ous stock solution and forskolin from a 30 mM 
stock solution in dimethylsulfoxide (DMSO). The 
final concentration of DMSO was 0.1% (v/v) 
under all experimental conditions. At this concen- 
tration DMSO did not interfere with any of the 
measurements performed. 
The materials and their sources were the same as 
those reported in [3,6]. 
3. RESULTS 
Membrane potential changes were assessed by 
using the fluorescent probe bis(l,3-dimethylthio- 
barbiturate) trimethineoxonol, bisoxonol [14], at a 
final concentration of 100 nM [3] and excitation 
and emission wavelengths at 540 and 580 nm, 
respectively. 
Insulin release was measured during perifusions 
of suspensions of quin2 loaded and control cells at 
concentrations of 1.5-4 x lo6 cells/chamber. The 
chamber volume was 700~1 and the cells were 
perifused with the same modified Krebs-Ringer- 
bicarbonate Hepes buffer as described above sup- 
plemented with 0.07% of bovine serum albumin. 
Perifusions were carried out at 37°C without gass- 
ing. The perifusion system has been described in 
[15]. The flow rate was 1 ml/min. The dead space 
time was 3 min and the results have been corrected 
accordingly. Insulin in the perifusate was 
measured by radioimmunoassay using rat insulin 
as standard. The insulin content of the cells prior 
to perifusion was measured following acid ethanol 
extraction [ 1 l] and the insulin release was express- 
ed as a percentage of the initial cellular hormone 
content, which averaged 425 f 49 ng/106 cells (n = 
5). 
In fig.1 the results are shown of an experiment 
investigating the effect of D-glyceraldehyde 
(10 mM) on membrane potential. [Ca*‘], and in- 
sulin release was tested in parallel on aliquots from 
the same batch of quin2 loaded cells. 
Glyceraldehyde started depolarizing the cells after 
a lag of lo-15 s. The membrane potential was 
maximally depolarized at 2 min, whereafter it 
gradually repolarized. [Ca*‘], increased more 
slowly than the membrane depolarization, but also 
reached its highest value after 2 min. A definite in- 
crease of insulin release in this experiment only 
began 2.5 min after the exposure of the cells to 
1OmM 
D-glyceraldohyde 
[W], M IO-‘- 
For the measurement of cellular cyclic AMP 
levels 0.8-l. 1 x lo6 cells were incubated in 1 ml of 
the modified Krebs-Ringer-bicarbonate buffer 
(0.5% bovine serum albumin) for 5 min at 37°C in 
the presence of test substances. Thereafter, two 
lOO-~1 aliquots of the cell suspension from each 
tube were boiled for 20 min after the addition of 
200~1 of 0.05 M acetate buffer (pH 6.2). The 
boiled samples were centrifuged for 10 min at 450 
x g; 100~1 of the supernatants were succinylated 
and cyclic AMP determined by radioimmunoassay 
as in [6]. 
l09- 
+ @ IOmM 
D-glycoraldohyde 
Results are given as means + SE and statistical 
analysis was by Student’s t:test for paired data 
Fig.1. Effect of D-glyceraldehyde (10 mM) on mem- 
(Ca’+i) or unpaired data (insulin released and 
brane potential (A), [Ca2’], (B) and immunoreactive 
insulin release (C) in RINmSF cells. Aliquots from the 
cyclic AMP). same batch of quin2 loaded cells were used. 
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glyceraldehyde. Mean values of [Ca2+]i and insulin 
release from several experiments are shown in 
fig.2. At 2 min, glyceraldehyde raised [Ca2+]i from 
123 + 11 to 210 f 15 nM. [Ca2+]i returned to 
prestimulatory levels again within 5 min. In the 
quin2 loaded cells the rate of insulin release in- 
creased after 2.5 min and thereafter reached a 
plateau about twice the basal rate beyond 3.5 min. 
The insulin release rate remained elevated even 
when [Ca’+]i had returned to basal values. 
Insulin release was also measured from control 
cells not loaded with quin2 in the same experiments 
(fig.2). Although the rate of insulin release was 
mrwtes 
- quin 2 loaded 
30 LO 50 60 70 
mvwtes 
Fig.2. Mean values of [Ca’+], and immunoreactive 
insulin release in response to D-glyceraldehyde. Quin2 
loaded and control cells were exposed to glyceraldehyde 
(10 mM) from minute 47.5 to minute 62.5 of a 70 min 
perfusion (3 separate experiments). 
slightly lower lrom quin2 loaded relative to control 
cells during the prestimulatory period, this dif- 
ference was not significant. Glyceraldehyde caused 
an almost 3-fold stimulation of insulin release 
from control cells. The pattern of the stimulated 
release was fairly similar in both groups of cells 
and in both cases the insulin release rate returned 
towards basal upon cessation of the stimulus. 
In fig.3 the effects are shown of forskolin on 
membrane potential, [Ca2+]i and insulin release 
from aliquots of the same batch of quin2 loaded 
cells. Forskolin (30,~M) did not alter membrane 
potential or [Ca2+]i but stimulated insulin release. 
Fig.4 gives the results of several experiments where 
forskolin was added to quin2 loaded cells for the 
assessment of [Ca2+]i and to both loaded and con- 
trol cells for the measurement of insulin release. 
There was no rise in [Ca2+]i whereas the rate of in- 
sulin release was stimulated significantly in both 
groups of cells. As [Ca’+]i in some experiments 
showed a slight drift upwards, we examined 
whether [Ca2+]i would increase with time. In two 
experiments where the cells were exposed to for- 
skolin during 10 min, no increase in [Ca2+]i 
occurred. 
As can be seen in fig.3A,B, glyceraldehyde still 
elicited membrane depolarization and a rise in 
Fig.3. Effect of forskolin (30 PM) and D-glyceraldehyde 
(10 mM) on membrane potential (A), [Ca2’], (B) and 
immunoreactive insulin release (C). Aliquots from the 
same batch of quin2 loaded cells were used. 
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Fig.4 Mean values of [Ca”], and immunoreactive 
insulin release in response to forskolin (30pM). The 
Perifusion protocol was the same as in fig.2 (3 separate 
experiments). 
[Ca’+]i when added to a cuvette already containing 
forskolin. The combination of forskolin and 
glyceraldehyde elicits insulin release which is 
greater than that seen with either substance alone 
(fig.3C). This is indicated in table 1, where 3 
perifusion experiments of quin2 loaded cells are 
summarized. The cells were exposed to forskolin, 
to glyceraldehyde and to the combination of the 
two. In the presence of forskolin, glyceraldehyde- 
-induced insulin release was potentiated 
significantly at 50 and 51 min, i.e., 2.5 and 
3.5 min after the beginning of the stimulation. 
Finally, cellular cyclic AMP levels were 
measured after a 5 min exposure to forskolin and 
glyceraldehyde. Forskolin (30 PM) increased the 
cyclic AMP levels from 5.0 + 0.3 to 14.4 + 
1.1 pmol/106 cells (n = 10, p < 0.001). The cellular 
cyclic AMP levels in the presence of glyceralde- 
hyde (10 mM) were 5.0 f 0.3 pmol/106 cells (n = 
10) and forskolin still increased cyclic AMP, in this 
case to 12.4 f 0.8 (n = 5) which was not signifi- 
cantly different from the level observed with 
forskolin alone. 
minutes 
Table 1 
Immunoreactive insulin release during perifusion of quin2 loaded RINmSF cells with forskolin, D- 
glyceraldehyde or the two substances combined 
Perifusion 
time 
(min) 
(I) (II) (III) P 
Forskolin D-Glyceraldehyde Forskolin + III vs II 
(30 PM) (10 mM) D-glyceraldehyde 
(Immunoreactive insulin % of cell content/min) 
47 0.14 * 0.03 0.12 * 0.02 0.16 + 0.02 >0.20 
49 0.16 + 0.03 0.21 * 0.03a 0.29 f 0.04b >O.lO 
50 0.18 * 0.01 0.23 + 0.03b 0.39 * 0.04d <O.Ol 
51 0.18 * 0.02 0.29 + 0.03’ 0.46 f 0.04d <0.02 
53 0.24 * 0.03 0.41 + 0.03d 0.53 ?? 0.07d >O.lO 
55 0.28 + 0.03b 0.39 + 0.04d 0.55 * 0.06d >0.05 
ap < 0.05 
bp < 0.02 
c p < 0.005 
d p < 0.001 vs prestimulatory values at 47 min 
Cells were perifused for 47.5 min with basal buffer and then exposed to the test substances (see also 
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4. DISCUSSION 
To measure [Ca’+]i and insulin secretion in 
parallel large amounts of cells in suspension are re- 
quired. Therefore, the cell line RINmSF was used 
rather than cells from pancreatic islets. This cell 
line has retained the capacity of increasing the rate 
of insulin release to a variety of secretagogues in- 
cluding glyceraldehyde, amino acids and glucagon 
13,lll. Because of an abnormal glucose 
metabolism, the cells are no longer sensitive to the 
secretagogue function of glucose [ 11,161. 
However, RINmSF cells provide a valid model 
system for the study of insulin release and the use 
of glyceraldehyde as a glucose-like means of 
stimulating release has recently been validated. 
Thus, it was found that glucose causes a similar 
rise in [Ca*+]i n pancreatic islet cells [4,5] as that 
seen with glyceraldehyde here, and in [3]. 
The rise in [Ca2+]i evoked by glyceraldehyde 
precedes the stimulation of insulin release but is 
transient, while the rate of insulin release remains 
elevated during continuous exposure to the 
stimulus. This finding suggests that a rise in [Ca”]i 
is necessary for the triggering of insulin release but 
not for the maintenance of elevated release rates. 
As membrane depolarization occurs early, it is 
reasonable to assume that Ca2+ enters the cells 
through voltage-dependent Cat+ channels. 
However, the channel blocker, verapamil, only in- 
hibits part of the rise in [Ca2+]i and the insulin 
release response [3,5]. Glyceraldehyde may thus 
raise [Ca2’]i by an additional mechanism not in- 
volving Ca2+ channels but perhaps the mobiliza- 
tion of stored calcium [S]. 
The 3-fold elevation of cellular cyclic AMP 
levels induced by forskolin resulted in an increase 
of insulin release without changing [Cat’&. Two 
other agents which raise cyclic AMP, glucagon 
(1 PM) a secretagogue in these cells [ll], and 
theophylline (2 mM) were also ineffective in 
elevating [Ca’+]i (not shown). It can thus be con- 
cluded that an increase in cyclic AMP does not 
mobilize calcium from cellular stores in insulin 
secreting cells. This result is not due to the failure 
of detecting Ca2+ mobilization with quin2, since 
carbamylcholine-evoked mobilization is clearly 
seen in these cells [17]. 
Forskolin, which also raises cyclic AMP levels in 
pancreatic islets [6,18] has been reported to in- 
crease glucose-induced electrical activity and 
45Ca2f uptake in mouse pancreatic islets [19,20]. 
We did not observe any depolarization of the 
average membrane potential nor a change in the 
capacity of glyceraldehyde to raise fCa”]i. If 
anything, the effect of glyceraldehyde was smaller 
in the presence than in the absence of forskolin, 
despite the potentiation of insulin release. There is, 
however, no fundamental difference between 
RINmSF cells and pancreatic islets, since, at low 
glucose, forskolin-stimulated insulin release from 
islets was not accompanied by depolarization or 
4SCa2+ uptake [ 19,201. 
It was of interest o note that forskolin enhanced 
glyceraldehyde-induced insulin release without a 
further rise in cyclic AMP levels. This situation is 
very similar to the interaction between high glucose 
concentrations and forskolin in pancreatic islets 
[6]. Thus, the most likely interpretation of the ac- 
tion of cyclic AMP in insulin release is that the 
nucleotide sensitizes the release machinery to other 
factors, such as the concentration of cytosolic free 
Ca’+. 
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